WSJ - March 28, 2019
Lisa Shulman, M.D., discusses her research that found most children who "recover" from autism still have difficulties that require therapeutic and educational support. Dr. Shulman is professor of pediatrics at Einstein and interim director of the Rose F. Kennedy Children’s Evaluation and Rehabilitation Center at Montefiore.
Dr. Shulman's ProfileMore coverage on Dr. Shulman
The New York Times - March 6, 2019
Joanna Starrels, M.D., M.S., helped draft the opioid prescription guidelines issued by the Centers for Disease Control and Prevention three years ago. Now, she is among the 300 signatories of a letter sent to the federal agency contending the guidelines are harming one group of vulnerable patients: those with severe chronic pain. Dr. Starrels is associate professor medicine at Einstein and an attending physician at Montefiore.
Dr. Starrels's ProfileMore coverage on Dr. Starrels
Kaiser Health News - March 5, 2019
Despite the "off-label" use of some drugs, like metformin, to fight the effects of aging, Nir Barzilai, M.D., believes rigorous clinical trials are necessary to prove their efficacy and safety. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair in Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
US News & World Report - February 12, 2019
Judith Wylie-Rosett, Ed.D., says losing weight and exercising can prevent prediabetes from progressing to Type 2 diabetes. Dr. Wylie-Rosett is professor and division chief of health promotion and nutrition research, Atran Foundation Chair in Social Medicine, and co-director of the New York Regional Center for Diabetes Translation Research.
Dr. Wylie-Rosett's ProfileMore coverage on Dr. Wylie-Rosett
NBC News - February 12, 2019
Harris Goldstein, M.D., says he is encouraged by the prospect of increased federal funds for regional AIDS research centers that help advance treatments and improve health outcomes. Dr. Goldstein is director of the Einstein-Rockefeller-CUNY Center for AIDS Research and an attending physician at Children’s Hospital at Montefiore.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
Scientific American - January 23, 2019
Research led by Kamran Khodakhah, Ph.D., proves for the first time that the cerebellum—long thought to be mainly involved in motor coordination—helps control addictive and social behavior. Dr. Khodakhah is professor and chair of the Dominick P. Purpura Department of Neuroscience at Einstein and Montefiore.
More CoverageDr. Khodakhah's Profile
The Atlantic - January 2, 2019
Harry Ostrer, M.D., says rare genetic diseases prevalent in Jews have been found in some Latin American populations, which suggests a hidden Jewish ancestry. Dr. Ostrer is professor of pathology and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore.
Dr. Ostrer's ProfileMore coverage on Dr. Ostrer
NPR - January 2, 2019
Eric Hollander, M.D., is conducting the first large clinical study in the United States to test the effectiveness of medical marijuana on certain behaviors in children with autism spectrum disorder. Dr. Hollander is professor of psychiatry and behavioral sciences at Einstein and director of the Autism and Obsessive Compulsive Spectrum Program at Einstein and Montefiore.
Dr. Hollander's ProfileMore coverage on Dr. Hollander
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons' Profile
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
More coverage on
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder